Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Dr. Burger LL Vector Cancer patent: METHODS FOR

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155026
(Total Views: 698)
Posted On: 08/09/2024 1:32:10 AM
Posted By: My69z
Dr. Burger LL Vector Cancer patent:

METHODS FOR TREATING OR
PREVENTING CANCERS INVOLVING THE ADMINISTRATION OF ANTI - CCR5 RECEPTOR AGENTS

Applicant : CytoDyn Inc. , 2 Vancouver , WA ( US )

Inventors : Denis BURGER , Vancouver , WA ( US ) ; Scott KELLY , Vancouver , WA

Related U.S. Application Data
Provisional application No. 62 / 882,353 , filed on Aug. 2 , 2019 ,provisional application No. 63 / 047,693 , filed on Jul . 2 , 2020

ABSTRACT
The present disclosure relates to the use of competitive inhibitors of the CCR5 receptor , such as the monoclonal antibody leronlimab , or binding fragments thereof , in the treatment or prevention of cancer .

Jump down to a couple of the #'s....

[ 0018 ] Additionally , in the present disclosure , leronlimab was found to be unexpectedly effective in preventing tumor growth in mouse models lacking T cells , indicating that leronlimab also modulates immunological responses and promote anti - tumor effects through NK cells , B cells , or both . Accordingly , the ability of leronlimab to modulate activity triggered by binding the CCR5 axis on non - T cells , for example , on NK cells , B cells , or both , was determined . Also , importantly , it was found that leronlimab is surprisingly effective in preventing tumor growth in mouse models based solely on its activity relative to non - T cells ; thus , suggesting a non - T cell therapeutic approach

[ 0022 ] In some embodiments , the present disclosure provides a method of treating , inhibiting , or preventing colon cancer metastasis comprising administering to a subject in need thereof an anti - CCR5 cell receptor binding agent comprising :
( a ) a leronlimab antibody , or binding fragment thereof ; ( b ) a nucleic acid encoding a leronlimab antibody , or binding fragment thereof c ) a VECTOR comprising a nucleic acid encoding a leronlimab antibody , or binding fragment thereof ; ( d ) a host cell comprising ( i ) a leronlimab antibody , or binding fragment thereof ,( ii ) a nucleic acid encoding a leronlimab antibody , or binding fragment thereof , or ( iii ) a VECTOR comprising a nucleic acid encoding a leronlimab antibody , or binding fragment thereof ; or ( e ) an anti - CCR5 cell receptor binding agent that does not have CCL5 agonist activity .

Jump down to EXAMPLES section:

Example 1
Effect of Leronlimab on Kinase Activation and Phosphorylation in CD4 + T Cells

Example 2
Leronlimab Prevents Cancer in an Immunocompromised Mouse Model

Example 3
Leronlimab Slows Development of XGVHD and Enhances Anti - Tumor Activity in a Humanized
Mouse Model of Colon Cancer

Example 4
Leronlimab Reduces Lung and Liver Metastatic Lesion Growth Rate in a Humanized Mouse Model of Colon Cancer

Example 5
Leronlimab Enhances Expression of Certain Immune Cells

Example 6
Leronlimab Inhibits Tumor - Associated Angiogene

Click on the PDF link:
https://patents.google.com/patent/US20220298249A1/fr
________

Cytodyn owns all work & Formulas produced:

https://contracts.justia.com/companies/cytody...ct/397946/

Until recent Dr. Sacha activities, never looked for a Vectoring aspect, let alone in this patent application.

But I'd be damed,we have a "vector" based patent for prevention AND treatment, of Colon Cancer.



(11)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us